New partnership empowers therapies of the future

Fraser McLeod shares his excitement for the emerging advancements in biopharma, and highlights how the acquisition of Wyatt brings a new class of instrumentation to Water’s portfolio, strengthening the company’s ability to serve customers in the biologics space.

This video was filmed at Analytica 2024.